Difference between revisions of "Team:Paris Bettencourt/Results"

 
(One intermediate revision by the same user not shown)
Line 5: Line 5:
 
     <img src="https://static.igem.org/mediawiki/2018/7/77/T--Paris_Bettencourt--Trophee_J.png"/>
 
     <img src="https://static.igem.org/mediawiki/2018/7/77/T--Paris_Bettencourt--Trophee_J.png"/>
 
</div>
 
</div>
 +
 
<div class='textbody h1'>
 
<div class='textbody h1'>
 
<h1>Key Results</h1>
 
<h1>Key Results</h1>
 
</div>
 
</div>
−
<div class='textbody'>
 
−
<p>
 
  
−
<div class='textbody h2'>
 
  
 +
<div class='textbody h2'>
 
<h2>Key results from the Human Practices</h2>
 
<h2>Key results from the Human Practices</h2>
 
</div>
 
</div>
−
<div class='textbody'>
 
  
 +
<div class='textbody'>
 
<td>
 
<td>
 
<li>By talking to experts, farmers and veterinaries, we identified that antimicrobial resistance of coliforms affecting piglets is a major concern</li>
 
<li>By talking to experts, farmers and veterinaries, we identified that antimicrobial resistance of coliforms affecting piglets is a major concern</li>
Line 26: Line 25:
 
<h2>Key results from the STAR CORE Design and Production</h2>
 
<h2>Key results from the STAR CORE Design and Production</h2>
 
</div>
 
</div>
 +
 
<div class='textbody'>
 
<div class='textbody'>
 
<td>
 
<td>
Line 55: Line 55:
 
<td>
 
<td>
 
<li>Decreasing net charge on the peptide improves expression efficiency, however it decreases its antibacterial activity</li>
 
<li>Decreasing net charge on the peptide improves expression efficiency, however it decreases its antibacterial activity</li>
−
 
 
</td>
 
</td>
 
</div>
 
</div>

Latest revision as of 12:19, 19 November 2018

Key Results

Key results from the Human Practices

  • By talking to experts, farmers and veterinaries, we identified that antimicrobial resistance of coliforms affecting piglets is a major concern
  • We obtained access to raw data from ANSES and found out that this data highlights amoxicillin and tetracycline as drugs with the most frequent evolved resistance

    • Key results from the STAR CORE Design and Production

  • We successfully cloned 131 STAR CORE combinations.
  • 9 out of the 11 proteins we expressed exhibited antibacterial activity comparable to existing antibiotics and AMPs.

    • Key results from the Testing

  • The STAR CORE we have obtained show antimicrobial activity.
  • 8 out of the 10 constructs showed antimicrobial activity towards E. coli while 9 out of the 10 constructs displayed antimicrobial potential towards B. subtilis.
  • The top performing STAR CORE was the Ferritin-Alyteserin fusion, with an activity almost 10 times higher than that of the control. Some StarCores exhibited species-specific killing, being particularly active against E. coli.
  • StarCores of varying geometry displayed similar MIC values.
  • There was no clear correlation between the geometry of the STAR CORE and their antimicrobial activity, indicating a non-specific mechanism of action.

    • Key results from Optimization and Modeling

  • Decreasing net charge on the peptide improves expression efficiency, however it decreases its antibacterial activity
    • Centre for Research and Interdisciplinarity (CRI)
    Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
    Paris Descartes University
    24, rue du Faubourg Saint Jacques
    75014 Paris, France
    paris-bettencourt-2018@cri-paris.org